Latest filing published 21 May 2025 for Treace Medical Concepts, INC..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Richard W. Mott on record concern Treace Medical Concepts, Inc., in the capacity of board member. Between 27 April 2021 and 20 May 2025, the trades on record add up to 32 filings.
The open-market side counts 4 purchases for €644k alongside 22 sales for €15.5M. The net balance comes to €14.8M on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 4 share grants.
A typical purchase (the median) is worth €118k. Of 4 purchases, 4 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
The record was last updated on 21 May 2025 with a share grant in Treace Medical Concepts, Inc. The most recent open-market purchase was published on 28 May 2024, 881 days ago. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations